传统PCI
经皮冠状动脉介入治疗
医学
炎症
血管成形术
心肌梗塞
心脏病学
气球
生物标志物
内科学
裸金属
药物洗脱支架
支架
再狭窄
生物化学
化学
作者
Ioannis Merinopoulos,Tharusha Gunawardena,Natasha Corballis,Vassiliki Tsampasian,Simon Eccleshall,James G W Smith,Vassilios Vassiliou
出处
期刊:Minerva cardiology and angiology
[Edizioni Minerva Medica]
日期:2022-07-01
标识
DOI:10.23736/s2724-5683.22.06091-4
摘要
The role of inflammation in percutaneous coronary intervention (PCI) has been investigated in numerous studies. Both pre- PCI and post- PCI inflammatory status have been demonstrated to be linked with patient outcomes. C-reactive protein (CRP) continues to be the most studied inflammatory biomarker, while a growing number of additional biomarkers, including cytokines and immune cells, are being assessed. As insights are gained into the complexities of the inflammatory response to PCI, it becomes evident that a targeted approach is necessary to ensure optimal patient outcomes. Here, we review the biomarkers that can predict patient outcomes following PCI and specifically how they differ for balloon angioplasty, bare metal stents and drug eluting stents. A specific focus is given to human studies and peri-procedural inflammation rather than inflammation associated with myocardial infarction.
科研通智能强力驱动
Strongly Powered by AbleSci AI